Late Phase II Study of TS-142 in Patients With Insomnia

  • participants needed
  • sponsor
    Taisho Pharmaceutical Co., Ltd.
Updated on 15 August 2022


This is a randomized, double-blind, multi-center, placebo-controlled, parallel-group exploratory study in patients with insomnia.

Condition Patients With Insomnia
Treatment TS-142
Clinical Study IdentifierNCT04469023
SponsorTaisho Pharmaceutical Co., Ltd.
Last Modified on15 August 2022

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note